No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Thermo Fisher Scientific Inc. is a prominent global entity that delivers a comprehensive suite of scientific instrumentation, specialized diagnostic offerings, laboratory supplies, biopharmaceutical services, and life science solutions. Its operational footprint extends across North America, Europe, Asia-Pacific, and other international regions. The company's Life Sciences Solutions division furnishes essential reagents, sophisticated instruments, and various consumables vital for biological and medical research, the advancement and manufacture of drugs and vaccines, and the identification of infections and diseases. This segment, encompassing biosciences, genetic sciences, and bioproduction, serves a broad spectrum of clients including pharmaceutical and biotechnology firms, agricultural businesses, clinical facilities, healthcare providers, academic institutions, and government agencies. Through its Analytical Instruments segment, the company supplies cutting-edge instruments, complementary consumables, software, and services to diverse sectors. These include pharmaceutical and biotechnology companies, academic and government research centers, environmental organizations, various industrial clients, and clinical diagnostic laboratories. The Specialty Diagnostics unit offers an array of diagnostic tools, including liquid, pre-mixed, and freeze-dried immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and specialized equipment. This segment also develops, produces, and markets complete blood test systems for the clinical detection and ongoing management of allergies, asthma, and autoimmune disorders. Additionally, it provides dehydrated and prepared culture media, sample collection and transport systems, related instrumentation, consumables, and human leukocyte antigen (HLA) typing and testing crucial for organ transplantation, as well as other general healthcare items. The Laboratory Products and Biopharma Services segment provides an extensive range of laboratory supplies, manages distribution for research and safety products, and delivers pharmaceutical services, including support for clinical research. The company's vast portfolio of products and services is distributed through multiple avenues: a dedicated direct sales team, customer service professionals, e-commerce platforms, and a network of third-party distributors. These offerings are marketed under well-recognized brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Founded in 1956, Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.
www.thermofisher.comNo one on the platform currently holds TMO.NE.
No tracked institution reports a position in TMO.NE as of their last filing.
No one on the platform has traded TMO.NE yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $46.5B | +5.1% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| TMO.NEThermo Fisher Scientific Inc. | $22.85 | +5.19% | $315.2B | — |
| AVCR.VAvricore Health Inc. | $0.06 | +0.00% | $6M | — |
| BUX.CNBioMark Diagnostics Inc. | $0.49 | +2.08% | $51M | — |
| EDT.TOSpectral Medical Inc. | $1.27 | -1.55% | $373M | — |
| IZO.CNIzotropic Corporation | $0.21 | +0.00% | $14M | — |
| MBX.TOMicrobix Biosystems Inc. | $0.31 | +0.00% | $43M | — |
| NLH.VNova Leap Health Corp. | $0.53 | +0.00% | $46M | — |
Source: Financial Modeling Prep · peers by sector/industry